Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.19.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Bridge Loan [Member]
Conversion of Convertible Note Payable [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Series A Redeemable Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Bridge Loan [Member]
Common Stock [Member]
Conversion of Convertible Note Payable [Member]
Common Stock [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Common Stock [Member]
Series A Redeemable Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Bridge Loan [Member]
Additional Paid-in Capital [Member]
Conversion of Convertible Note Payable [Member]
Additional Paid-in Capital [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series A Redeemable Convertible Preferred Stock [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2016 $ (45,525)         $ 4         $ (293)         $ (45,236)  
Beginning balance, shares at Dec. 31, 2016           2,620,803                      
Issuance of common stock 56,342 $ 3,666       $ 4         56,338 $ 3,666          
Issuance of common stock, shares           3,621,250 300,000                    
Conversion of preferred stock       $ 18,668 $ 8,598       $ 2 $ 3       $ 18,666 $ 8,595    
Conversion of preferred stock, shares                 2,309,135 2,922,798              
Exercise of Primary Warrant 29,263         $ 2         29,261            
Exercise of Primary Warrant, shares           2,150,335                      
Conversion of debt and accrued interest   $ 8,045 $ 20,737         $ 1       $ 8,045 $ 20,736        
Conversion of debt and accrued interest, shares             590,717 1,523,746                  
Issuance of restricted stock, net of forfeitures (33)                   (33)            
Issuance of restricted stock, net of forfeitures, shares           22,963                      
Buy-back/Repurchase of common stock (56)                   (56)            
Buy-back/Repurchase of common stock, shares           (7,500)                      
Exercise of options 131                   131            
Exercise of options, shares           80,829                      
Common stock issued to service provider, shares           6,000                      
Issuance of warrants 8,658                   8,658            
Beneficial conversion feature 554                   554            
Modification of warrants 371                   371            
Stock-based compensation expense 16,089                   16,089            
Stock-based compensation expense, shares           23,807                      
Accretion of redeemable convertible preferred stock (4,470)                             (4,470)  
Net loss (59,601)                             (59,601)  
Other comprehensive gain (loss) (135)                               $ (135)
Ending balance at Dec. 31, 2017 61,302         $ 16         170,728         (109,307) (135)
Ending balance, shares at Dec. 31, 2017           16,158,883                      
Issuance of common stock 32,770         $ 2         32,768            
Issuance of common stock, shares           1,955,000                      
Exercise of options 532                   532            
Exercise of options, shares           151,121                      
Common stock purchases under employee stock purchase plan 1,026                   1,026            
Common stock purchases under employee stock purchase plan, shares           80,654                      
Common stock issued to service provider, shares           7,412                      
Common stock issued upon vesting of restricted stock units, shares           44,786                      
Forfeitures of restricted stock, shares           (4,184)                      
Common stock issued for acquisitions 10,128         $ 1         10,127            
Common stock issued for acquisitions, shares           941,548                      
Stock-based compensation expense 15,493                   15,493            
Net loss (61,104)                             (61,104)  
Other comprehensive gain (loss) 136                               136
Ending balance at Dec. 31, 2018 $ 60,283         $ 19         $ 230,674         $ (170,411) $ 1
Ending balance, shares at Dec. 31, 2018           19,335,220